Mechanism and clinical evaluation of Lefamulin: a new therapeutic agent for community-acquired bacterium pneumonia

doi:10.3969/j.issn.1672-3384.2020.07.005

LI Shao-qiang, FENG Yu-fei, HU Xin

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (7) : 16-20.

PDF(480 KB)

Clinical Medication Journal ›› 2020, Vol. 18 ›› Issue (7) : 16-20. DOI: 10.3969/j.issn.1672-3384.2020.07.005

New Drugs

Mechanism and clinical evaluation of Lefamulin: a new therapeutic agent for community-acquired bacterium pneumonia

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 18(7): 16-20 https://doi.org/10.3969/j.issn.1672-3384.2020.07.005

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(480 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export